Clinical Trial Update: Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and pharmacokinetics of CKD-330 8/5 mg when coadministered with two separate drugs in hypertension; the trial status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CKD-330
• Two separate coadministered drugs (names undisclosed)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Hypertension | Phase 1 | Status: COMPLETED